These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30105268)

  • 1. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer.
    Kurtenkov O; Innos K; Sergejev B; Klaamas K
    Biomed Res Int; 2018; 2018():9579828. PubMed ID: 30105268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
    Kurtenkov O; Bubina M; Klaamas K
    Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
    Kurtenkov O; Klaamas K
    Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
    Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
    Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance.
    Kurtenkov O; Klaamas K
    Biomed Res Int; 2017; 2017():6097647. PubMed ID: 28316982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
    Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
    World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
    Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
    Kodar K; Kurtenkov O; Klaamas K
    Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.
    Kurtenkov O
    Biomed Res Int; 2020; 2020():9747040. PubMed ID: 32280709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
    Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
    J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR; Sauter ER; Quinn TP; Deutscher SL
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
    Kurtenkov O; Klaamas K; Rittenhouse-Olson K; Vahter L; Sergejev B; Miljukhina L; Shljapnikova L
    Exp Oncol; 2005 Jun; 27(2):136-40. PubMed ID: 15995632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.
    Newman RA; Klein PJ; Uhlenbruck G; Citoler P; Karduck D
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):181-8. PubMed ID: 374421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients.
    Wolf MF; Ludwig A; Fritz P; Schumacher K
    Tumour Biol; 1988; 9(4):190-4. PubMed ID: 3420374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
    World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates].
    Smorodin EP; Jansson B; Miliukhina L; Paaski G; Bovin NV; Ovchinnikova TV; Kurtenkov O
    Bioorg Khim; 1997 Oct; 23(10):795-9. PubMed ID: 9490614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.